Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: -
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Fennec Pharmaceuticals Inc

AHX:CN

Ticker Change

Company Profile for Fennec Pharmaceuticals Inc (AHX)

Fennec Pharmaceuticals Inc. is a biotechnology company that develops therapeutic drugs for the treatment of cancer. The Company's lead biotechnology compound works to kill tumor cells (by apoptosis) destroy the blood vessels that feed a cancerous tumor, essentially destroying the tumor's food supply by targeting the cell adhesion molecule N-cadherm.

Contact Information

Fennec Pharmaceuticals Inc

68 TW Alexander Drive
Reasearch Triangle Park, NC 27709
United States
Phone: 1-919-636-4530
Fax: 1-919-890-0490

Key Executives for Fennec Pharmaceuticals Inc (AHX)

Rostislav Raykov "Rosty"Chairman/CEOKrysia LynesInterim CFO

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil